Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-05

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for Bupropion Hydrochloride from BluePoint Laboratories. This action updates the approved generic product (ANDA 0761…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)